1RAFAEL CARMENA,PATRICK DURIEZ,JEAN-CHARLES FRUCHART,et al.Atherogenic lipoprotein particles in atherosclerosis[J].Circulation,2004,109(1):2-7.
2ANTONIO M GOTTO J R,ELIOT A,BRINTON.Assessing low level of high-density lipoprotein cholesterol as a risk factor in coronary heart disease:a working group report and update[J].J Am Coll Cardiol,2004,43:717-724.
4VINK A,PASTERKAMP G.Atherosclerotic palque burden,plaque vulnerability and arterial remodeling:the role of inflammation[J].Minerva Cardioangiol,2002,50:75-83.
5BOGER R H,BODE-BOGER S M,Szuba A,et al.Asymmetric dimethylarginine(ADMA):a noval risk factor for endothelialdys function-its role in hypercholesterolemia[J].Circulation,1998,98:1842-1847.
6ERIC DE GROOT,KEES HOVINGH,ALBERT WIGEAM,et al.Measurement of arterial wall thickness as a surrogate marker for atherosclerosis[J].Circulation,2004,109(1):33-38.
7BENNER.Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy[J].Am J Health Syst Pharm,2005,62:1468-1475.
8PIERRE AMARENCO,JULIEN lABREUCHE,PHILIPPA LAVALLEE,et al.Statins in stroke prevention and carotid atherosclerosi:systematic review and up-todate meta-analysis[J].Stroke,2004,35:2902-2909.
9RICHARD W,GRANT,KATHLEEN M,O' LEARY,JEFFREY B,et al.Impact of concurrent medication use on statin adherence and refill persistence[J].Arch Intern Med,2004,164:2343-2348.
同被引文献33
1Weihua Xiao~1 1 University of Science and Technology of China,China.2 Laboratory of Molecular Immunoregulation,NCI-Frederick,Frederick.MD 21702.USA..Advances in NF-κB Signaling Transduction and Transcription[J].Cellular & Molecular Immunology,2004,1(6):425-435. 被引量：22
5Hansson GK. Inflammation, atherosclerosis, and coronary artery dis- ease[ J]. N Engl J Meal,2005,353(4) :429-430.
6Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s [ J ]. Nature, 1993,362 ( 6423 ) : 801-809.
7Silva AP, Cavadas C, Baisse-Agushi B, et al. NPY, NPY receptors, and DPP IV activity are modulated by LPS ,TNF-a and IFN-g in HU- VEC [ J ]. Regulatory Peptides, 2003,116 ( 1 ) :71-79.
8de Groot E,Hovingh GK, Wigeam A, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis [ J ]. Circula- t/on,2004,109(23Supple 1 ) : Ⅲ33-Ⅲ38.
9Libby P,Okamoto Y,Rocha VZ, et al. Inflammation in atherosclero- sis : transition from theory to practice [ J ] . CircJ, 2010,74 ( 2 ) : 213- 220.
10John S, Schlaich M, Langenfeld M, et al. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic pa- tients : a randomized, placebo-controlled, double-blind study [ J ]. Cir- culation, 1998,98 ( 3 ) : 211-216.
